Search
Selected: U

Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .alpha..sub.1A -selective adrenoceptor agonists for the t

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .alpha..sub.1C specific compounds to treat benign prostat

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .alpha..sub.1c specific compounds to treat benign prostat

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .beta.-(fluoromethylene)-5-hydroxytryptophan and derivati

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .beta.-adrenergic agonists to treat patients with demyeli

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .beta.-receptor blocking agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .DELTA.5 androstenes in the treatment of HIV wasting synd

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alph

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .omega.-3-fatty acids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of .omega.-conotoxin analogs for treating retinal and optic

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,2-Bridged 1,4-dihydropyridines as medicaments

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,2-bridged 1,4-dihydropyridines as medicaments

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,2-dipalmitoyl-L-.alpha.-phosphatidyl-N,N-dimethylethano

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,3,5-triazine-2,4,6-tris-alkylaminocarboxylic acid deriv

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,3-oxathiolane nucleoside analogues in the treatment of

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,3-oxathiolane nucleoside analogues in the treatment...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,4-benzothiazepine derivatives as drugs for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1,4-dihydropyridine derivatives and combinations thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.